Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Net Income 2017–2025
Aquestive Therapeutics Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Aquestive Therapeutics Inc. net income for the quarter ending March 31, 2026 was -8.1 M, a 64.86% decrease year-over-year.
- Aquestive Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -60.0 M, a 106.00% increase year-over-year.
- Aquestive Therapeutics Inc. annual net income for 2025 was -83.8 M, a 89.83% increase from 2024.
- Aquestive Therapeutics Inc. annual net income for 2024 was -44.1 M, a 460.83% increase from 2023.
- Aquestive Therapeutics Inc. annual net income for 2023 was -7.9 M, a 85.54% decrease from 2022.
- Aquestive Therapeutics Inc. annual net income for 2022 was -54.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aquestive Therapeutics Inc. Net Income — FAQ
Aquestive Therapeutics Inc. (AQST) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Aquestive Therapeutics Inc.'s net income?
Aquestive Therapeutics Inc. (AQST) reported net income of -$84M for fiscal 2025.
Where can I see AQST's net income history?
The chart and table above show Aquestive Therapeutics Inc.'s net income by year and by quarter, including the growth rate.